Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Change in Cash (2018 - 2025)

Inmune Bio (INMB) has disclosed Change in Cash for 8 consecutive years, with -$3.0 million as the latest value for Q4 2025.

  • Quarterly Change in Cash rose 76.38% to -$3.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $3.8 million through Dec 2025, up 125.65% year-over-year, with the annual reading at $3.8 million for FY2025, 125.65% up from the prior year.
  • Change in Cash hit -$3.0 million in Q4 2025 for Inmune Bio, up from -$5.6 million in the prior quarter.
  • In the past five years, Change in Cash ranged from a high of $45.0 million in Q3 2021 to a low of -$12.6 million in Q4 2024.
  • Historically, Change in Cash has averaged $139200.0 across 5 years, with a median of -$4.5 million in 2022.
  • Biggest five-year swings in Change in Cash: surged 2294.65% in 2021 and later plummeted 756.17% in 2024.
  • Year by year, Change in Cash stood at -$9.7 million in 2021, then soared by 45.64% to -$5.3 million in 2022, then decreased by 13.58% to -$6.0 million in 2023, then plummeted by 111.74% to -$12.6 million in 2024, then skyrocketed by 76.38% to -$3.0 million in 2025.
  • Business Quant data shows Change in Cash for INMB at -$3.0 million in Q4 2025, -$5.6 million in Q3 2025, and $14.0 million in Q2 2025.